After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
Road accidents are a major reason for untimely deaths in cities. To reduce these deaths, many cou
lack of face, collapse in J&K; How the exit of Ghulam Nabi Azad will hurt Congress
The exit of Ghulam Nabi Azad from Congress appears to be just another episode of the series of le
RR vs CSK: Vaibhav Goes on the Attack—Rajasthan Crushes CSK to Record Their Biggest Victory
Indian cricket’s young sensation, Vaibhav Suryavanshi, unleashed such a batting onslaught a
The controversy surrounding Vipul Shah's "The Kerala Story 2: Goes Beyond" began as soon as the f
Ambani: Anant Ambani and Radhika Merchant stopped, the ceremony was held at Shrinathji temple
Anant Ambani, the younger son of Reliance chief Mukesh and Nita Ambani, has been stopped. Very so
The Central Government has banned the Popular Front of India (PFI) for five years for being in co
Amid the NEET-UG controversy, the Supreme Court issued notice to the Center and the National Test
Jammu Kashmir: Tension after hate speech in Bhaderwah, the administration imposed a curfew
Conspiracies are continuing to create tension in Bhaderwah (Doda) and Kishtwar districts through
Congress President Poll: After 24 years in the Congress, which is often surrounded by dynastic al
Ukraine has also ordered a general mobilization of its countrymen to be deployed in Maidan-e-Jung
